Zacks Rating on Lannett Co Inc (LCI)

Lannett Co Inc (LCI) : Zacks Investment Research ranks Lannett Co Inc (LCI) as 3, which is a Hold recommendation. 2 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 1 other analysts are mildly bullish on the stock and favor a Buy. A total of 2 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 5 research analysts is 2, which indicates as a Buy.

Lannett Co Inc (LCI) : Currently there are 4 street experts covering Lannett Co Inc (LCI) stock. The most bullish and bearish price target for the stock is $35 and $26 respectively for the short term. The average price target of all the analysts comes to $29.88. The estimated standard deviation from the target is $4.01.


Shares of Lannett Company, Inc. rose by 3.92% in the last five trading days and 5.41% for the last 4 weeks. Lannett Company, Inc. is up 39.91% in the last 3-month period. Year-to-Date the stock performance stands at -19.44%. Lannett Co Inc (NYSE:LCI): stock turned positive on Tuesday. Though the stock opened at $31.65, the bulls momentum made the stock top out at $32.72 level for the day. The stock recorded a low of $31.65 and closed the trading day at $32.32, in the green by 2.83%. The total traded volume for the day was 1,116,401. The stock had closed at $31.43 in the previous days trading.

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Companys products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products, such as Cocaine Topical Solution (C-Topical), Morphine Sulfate Oral Solution, Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.